Trials / Completed
CompletedNCT01736423
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Female
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of YM060 once daily for female patients with diarrhea-predominant irritable bowel syndrome (D-IBS) for a long-term period (up to 52 weeks).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM060 | oral |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-11-29
- Last updated
- 2015-10-12
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01736423. Inclusion in this directory is not an endorsement.